Scarica l'app Stockscreener
0.287
0.93%
-0.0027
Pre-mercato:
.28
-0.007
-2.44%
Precedente Chiudi:
$0.2897
Aprire:
$0.2813
Volume 24 ore:
307.35K
Relative Volume:
0.12
Capitalizzazione di mercato:
$11.79M
Reddito:
$656.60K
Utile/perdita netta:
$-16.79M
Rapporto P/E:
-0.2672
EPS:
-1.0743
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
-8.37%
1M Prestazione:
-33.66%
6M Prestazione:
-37.62%
1 anno Prestazione:
-66.56%
Intervallo 1D:
$0.279
$0.29
Intervallo di 1 settimana:
$0.2775
$0.349
Portata 52W:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Nome
Scienture Holdings Inc
Settore
Industria
Telefono
(800) 261 0281
Indirizzo
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, MEDS, POM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.287 | 11.79M | 656.60K | -16.79M | -11.12M | -1.0743 |
HITI
High Tide Inc
|
2.695 | 240.24M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.555 | 33.71M | 179.02M | -57.29M | -33.01M | -2.7487 |
MEDS
Trxade Health Inc
|
3.50 | 11.19M | 7.15M | 4.03M | -11.33M | -5.40 |
POM
Pomdoctor Ltd Adr
|
0.97 | 8.99M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Borsa (SCNX) Ultime notizie
SCNX Looks 12.9% Overvalued on GF Value™ - GuruFocus
Premarket Movers: Gainers and Losers for Sept. 22, 2026 - ChartMill
Scienture secures distribution deal for naloxone nasal spray - Investing.com
A nasal spray for opioid overdoses is headed to 2,000 clinics - Stock Titan
Scienture Holdings Inc. (SCNX) Q2 2026 Earnings: EPS Loss Narrower Than Estimated Despite Absence of Reported RevenueDebt Analysis Report - careplusvn.com
SCNX Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, but Shares SlipEarnings Momentum Score - careplusvn.com
Scienture Holdings (NASDAQ: SCNX) Releases Updated Investor Presentation for Upcoming Analyst Meetings - Kalkine Media
Scienture Holdings Updates Investor Presentation and Guidance - TipRanks
SCNX: Two new therapies launched in 2026 drive revenue growth and pipeline momentum - TradingView
SCNX: Two new therapies launched in 2026 drive revenue growth and pipeline expansion - TradingView
Scienture Holdings at H.C. Wainwright: growth through niche drugs By Investing.com - Investing.com UK
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 - marketscreener.com
Enterprise value to revenue forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture (SCNX) CFO shows no personal stake in company stock - stocktitan.net
Scienture Holdings CFO Eric Sherb files initial beneficial ownership statement - Bitget
SCNX | Scienture Holdings, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Scienture (SCNX) Levels: Finishes 4.68% Down at $0.45 on the Day; Trading Range: Price Remains Between $0.43 Support and $0.47 Resistance in the Available RecordWyckoff Upthrust - vinanet.vn
Scienture (SCNX) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day; Post-Report: Shares Fall 0.49% in the Latest SessionEarnings Growth Forecast - vinanet.vn
Scienture Q2 Revenue Surges 510% Sequentially on Commercial Product Growth - Minichart
Scienture Q2 Revenue Reaches $343,639 as Net Loss Narrows 58% - Quiver Quantitative
Scienture stock jumps 21% on REZENOPY commercial launch - scanx.trade
Scienture (SCNX) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day; Post-Report - dars.gov.et
Scienture (SCNX) Q1 2026 Results: Profit Per Share Clears Its Benchmark in the Latest Session; Closing Reaction: Shares Rise 3.76% in Latest TradingOperating Income Trends - vinanet.vn
$Scienture Holdings (SCNX.US)$ LMAO. They give us a buy rating, but wont let us buy. - Moomoo
SCNX Q1 2026 Earnings: Loss Narrower Than Expected, Shares Rise 2.18%Earnings Analysis - vinanet.vn
SCNX Q1 2026 Earnings: Narrower Loss Beats Estimates, but Shares SlipEarnings Analysis - vinanet.vn
Scienture Holdings 2Q Loss/Shr 7c >SCNX - moomoo.com
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance - The Manila Times
Scienture Holdings: Q2 Earnings Snapshot - marketscreener.com
Scienture Holdings (SCNX) grows ARBLI revenue but remains loss-making in Q2 2026 - Stock Titan
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product - Yahoo Finance
Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com Nigeria
Scienture launches naloxone nasal spray for opioid overdose - Investing.com
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - marketscreener.com
Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg - marketscreener.com
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US - Yahoo Finance
Scienture Holdings Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView
Scienture Holdings Inc (SCNX) Stock News Today - TradingKey
Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SCNX Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 64.35%Estimate Revision Count - dars.gov.et
Scienture Holdings (SCNX) Holds Near $0.38 as Trading Range Tightens Between $0.36 Support and $0.40 ResistanceComposite Profile - dars.gov.et
Scienture Holdings, Inc. (NASDAQ: SCNX) Stock Price, News & Analysis - Kalkine
SCNX Q1 2026 Earnings: Narrower Loss Beats Estimates, But Shares Slide 4%One-Time Gain Impact - careplusvn.com
Scienture Holdings, Inc. Revenue Breakdown – NASDAQ:SCNX - TradingView
Scienture Holdings Inc (SCNX) Cash Flow - TradingKey
Scienture Holdings Inc (SCNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable? - simplywall.st
Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scienture Holdings Inc Azioni (SCNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.62%
21.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):